MAFLD in Egyptian non-dialysis CKD Patients: Frequency, fibrosis severity, and risk factors
MAFLD is highly prevalent among non-dialysis CKD patients, driven by shared metabolic abnormalities and CKD severity. These findings highlight the bidirectional relationship between MAFLD and CKD, emphasizing the need for integrated screening and management strategies to mitigate progression risks in this population.
Authors
- Hala Mohamed Hassanin
- Safaa M Abdelhalim (ORCID: https://orcid.org/0009-0006-0870-5808)
- Zienab M Saad (ORCID: https://orcid.org/0000-0001-9913-5826)
- Mahmoud M. Higazi (ORCID: https://orcid.org/0000-0003-3115-1939)
- Hesham Kamal Habeeb Keryakos (ORCID: https://orcid.org/0000-0003-3443-6390)
- Doaa Elzaeem Ismail (ORCID: https://orcid.org/0000-0003-4845-408X)
- Manar M. Sayed (ORCID: https://orcid.org/0009-0009-7698-3510)
Institutions
- Minia University (EG)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-11-24
- DOI
- https://doi.org/10.1371/journal.pone.0336568
- Primary Topic
- Chronic Kidney Disease and Diabetes
- Type
- article
- Field-Weighted Citation Impact
- 0.00